What Brexit means for drug regulation

What Brexit means for drug regulation

July 14, 2017, Pharmafile

Grant Castle is quoted in a Pharmafile article regarding how Brexit may affect drug regulation. “Even if we enter into a close free-trade agreement, the UK will lose influence in the development of pharmaceutical legislation and policy, and will also lose influence in the pharmaceutical regulatory procedures,” says Castle. “And that must inevitably mean that companies shift their focus to more influential jurisdictions.”